Cargando…

Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?

Detalles Bibliográficos
Autores principales:	Liu, Chia-Chia, Wang, Xiao-Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259257/ https://www.ncbi.nlm.nih.gov/pubmed/37306551 http://dx.doi.org/10.18632/oncotarget.28438

Ejemplares similares

Estrogen response in luminal breast cancer
por: Rangel, Leticia B. A., et al.
Publicado: (2013)

Mutations in Noncoding Cis-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast Cancer
por: El Ghamrasni, Samah, et al.
Publicado: (2022)

GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer
por: Kumegawa, Kohei, et al.
Publicado: (2022)

Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers
por: Kim, Jin-Ah, et al.
Publicado: (2016)

Discovery of CTCF-Sensitive Cis-Spliced Fusion RNAs between Adjacent Genes in Human Prostate Cells
por: Qin, Fujun, et al.
Publicado: (2015)

Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?
por: Ji, Guangjie, et al.
Publicado: (2017)

Dimensions of Pathological Aggression: From Neurobiology to Therapy
por: Wagels, Lisa, et al.
Publicado: (2022)

Correction: Discovery of CTCF-Sensitive Cis-Spliced Fusion RNAs between Adjacent Genes in Human Prostate Cells
por: Qin, Fujun, et al.
Publicado: (2015)

CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer
por: Viotto, Davide, et al.
Publicado: (2020)

Extracellular Vesicles Induce an Aggressive Phenotype in Luminal Breast Cancer Cells Via PKM2 Phosphorylation
por: Kang, Seo Young, et al.
Publicado: (2021)

A Regulatory Axis between Epithelial Splicing Regulatory Proteins and Estrogen Receptor α Modulates the Alternative Transcriptome of Luminal Breast Cancer
por: Elhasnaoui, Jamal, et al.
Publicado: (2022)

The Role of Luminance and Chromaticity on Symmetry Detection
por: Wu, Chia-Ching
Publicado: (2011)

MEL-18, a tumor suppressor for aggressive breast cancer
por: Lee, Jeong-Yeon, et al.
Publicado: (2015)

Understanding Breast Cancer Aggressiveness and Its Implications in Diagnosis and Treatment
por: Afifi, Nader, et al.
Publicado: (2023)

The luminal-basal paradigm in the urothelial cancer: hope for individualized approach
por: Reis, Leonardo Oliveira
Publicado: (2016)

Alternative splicing of CERS2 promotes cell proliferation and migration in luminal B subtype breast cancer cells
por: Pani, Trishna, et al.
Publicado: (2021)

GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer
por: Guo, Yanxia, et al.
Publicado: (2019)

Mutation hotspots in cis-regulatory regions in cancer
por: Poulos, Rebecca C., et al.
Publicado: (2016)

Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers
por: Phillips, John W., et al.
Publicado: (2020)

Integrative transcriptome sequencing reveals extensive alternative trans-splicing and cis-backsplicing in human cells
por: Chuang, Trees-Juen, et al.
Publicado: (2018)

Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database
por: Fabiano, Verónica, et al.
Publicado: (2020)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

Molecular heterogeneity of luminal breast cancer
por: Loi, S
Publicado: (2011)

More aggressive intrarenal endoscopic maneuvers are assuring a stone free outcome and safety
por: Antoniewicz, Artur A.
Publicado: (2015)

Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer
por: Advani, Rahul, et al.
Publicado: (2023)

Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer
por: Fici, Pietro, et al.
Publicado: (2016)

Computational Pathology for Breast Cancer and Gynecologic Cancer
por: Wang, Ching-Wei, et al.
Publicado: (2023)

G9a Knockdown Suppresses Cancer Aggressiveness by Facilitating Smad Protein Phosphorylation through Increasing BMP5 Expression in Luminal A Type Breast Cancer
por: Jin, Yunho, et al.
Publicado: (2022)

Molecular pathology of the luminal class of urothelial tumors
por: Bernardo, Carina, et al.
Publicado: (2019)

Alternative Splicing and Cancer
por: Auboeuf, Didier, et al.
Publicado: (2012)

The molecular profile of luminal B breast cancer
por: Creighton, Chad J
Publicado: (2012)

Path to Clonal Theranostics in Luminal Breast Cancers
por: Hajjaji, Nawale, et al.
Publicado: (2022)

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

A comprehensive characterization of cis-acting splicing-associated variants in human cancer
por: Shiraishi, Yuichi, et al.
Publicado: (2018)

Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
por: Elrashdy, Fatma, et al.
Publicado: (2020)

Prognostic Value of Lymphangiogenesis Determinants in Luminal and Non-luminal Breast Carcinomas
por: Widodo, Irianiwati, et al.
Publicado: (2018)

Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case report
por: Allegretti, Matteo, et al.
Publicado: (2023)

Protein-based immune profiles of basal-like vs. luminal breast cancers
por: Walens, Andrea, et al.
Publicado: (2021)

Genomic Mapping of Splicing-Related Genes Identify Amplifications in LSM1, CLNS1A, and ILF2 in Luminal Breast Cancer
por: Noblejas-López, María del Mar, et al.
Publicado: (2021)

Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
por: Garufi, Giovanna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b8h690c4gs6lnamgrv4q1921ev